Odyssey Therapeutics, Inc. Stock Analysis & AI Score
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Odyssey Therapeutics, Inc. (ODTX) holds an ST Score of 74.7 out of 100 (B+), with its strongest factor being Valuation (A) and its weakest Growth (B-). Analysts rate ODTX Buy across 2 ratings with a $38.00 average price target (+0.6% vs the current $24.38).
- Strongest
- ValuationA
- Weakest
- GrowthB-
All factor grades
- ValuationA
- ProfitabilityA
- MomentumA-
- ForecastB+
- Financial StrengthB
- GrowthB-
Contact
ODTX stock: frequently asked questions
What is ODTX's ST Score?
Odyssey Therapeutics, Inc. (ODTX) has an ST Score of 74.7 out of 100, an overall grade of B+. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is ODTX a buy, sell, or hold?
Wall Street's consensus rating on ODTX is Buy based on 2 analyst ratings. Our own ST Score grades it B+ (74.7/100). This is data, not investment advice — always do your own research.
What is ODTX's valuation grade?
Odyssey Therapeutics, Inc. (ODTX) earns a valuation grade of A, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is ODTX's growth grade?
Odyssey Therapeutics, Inc. (ODTX) earns a growth grade of B-, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is ODTX's profitability grade?
Odyssey Therapeutics, Inc. (ODTX) earns a profitability grade of A, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is ODTX's financial strength grade?
Odyssey Therapeutics, Inc. (ODTX) earns a financial strength grade of B, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for ODTX?
The average analyst price target for Odyssey Therapeutics, Inc. (ODTX) is $38.00 from 2 analysts, which is +0.6% versus the recent price of $24.38.